TÜRKÇE
Gazi University
Information Package
Home
Information on the Institution
Information on Degree Programmes
Information for Students
HOME
»
GRADUATE SCHOOL OF HEALTH SCIENCES
» DEPARTMENT OF PHARMACEUTICAL TECHNOLOGY
Programme Information
Qualification Awarded
Course Structure Diagram with Credits
Program Learning Outcomes
Course&Program L. Outcomes
Teaching & Learning Methods
Specific Admission Requirements
Recognition of Prior Learning
Graduation Requirements
Occupational Profiles of Graduates
Access to Further Studies
Examination Regulations, Assessment and Grading
Mode of Study
Profile of the Programme
Programme Director & ECTS Coord.
Search
GAZI UNIVERSITY INFORMATION PACKAGE - 2019 ACADEMIC YEAR
Course&Program L. Outcomes
--The Matrix for Course & Program Learning Outcomes
COURSE
PROGRAM LEARNING OUTCOMES
1
2
3
4
5
6
7
8
9
10
1110999-MASTER SCIENCE THESIS PERIOD
5
5
5
5
5
5
5
5
5
5
2110999-SPECIAL STUDIES IN MSC.
5
5
5
5
5
5
5
5
5
5
6110999-THESIS PREPARATION
5
5
5
5
5
5
5
5
5
5
FTE-1002-SEMINAR
5
5
5
5
5
5
5
5
5
5
FTE-1010 -BASIC PROCESS IN THE PHARMACEUTICAL TECHNOLOGY
4
4
1
4
2
2
1
1
3
1
FTE-1011 -BASIC PROCESS IN THE PHARMACEUTICAL TECHNOLOGY-PRACTICE
4
4
1
4
2
2
1
1
3
1
FTE-1020 -PHYSICAL PHARMACY
3
4
2
2
2
3
1
3
4
2
FTE-1031 -PRE-FORMULATION – PRACTICE
5
5
4
3
5
4
4
3
5
4
FTE-1041 -KINETIC PRINCIPLES AND STABILTY-PRACTICE
5
5
4
5
5
5
4
3
5
5
FTE-1050 -PARENTERAL SOLUTION AND OTHER STERIL PRODUCT TECHNOLOGY
5
5
5
5
5
2
3
1
5
5
FTE-1051 -PARENTERAL SOLUTION AND OTHER STERIL PRODUCT TECHNOLOGY- PRACTICE
5
5
5
5
5
2
3
1
5
5
FTE-1070 -RADIOPHARMACEUTICS I
5
5
4
5
5
5
4
3
5
5
FTE-1081 -BASIC PHARMACOKINETICS AND BIOPHARMACEUTICS-PRACTICE
5
5
3
3
2
5
1
1
5
5
FTE-1090 -PHARMACEUTICAL BIOTECHNOLOGY I:BASIC PRINCIPLES
4
4
2
4
4
5
5
5
4
4
FTE-1110-SCIENTIFIC RESEARCH METHODS AND RESEARCH-PUBLICATION ETHICS
1
1
2
1
1
1
0
0
3
3
FTE-1120-PRE-FORMULATION
5
5
5
5
5
5
4
4
5
5
FTE-1130-KINETIC PRINCIPLES AND STABILITY
5
5
3
5
4
5
3
5
5
5
FTE-1140-BASIC PHARMACOKINETICS AND BIOPHARMACEUTICS
5
5
3
3
4
5
4
0
5
5
FTE-2002-SEMINAR
5
5
5
5
5
4
5
5
5
5
FTE-2020 -TABLET TECHNOLOGY
5
4
4
4
5
4
1
1
5
4
FTE-2021 -TABLET TECHNOLOGY - PRACTICE
4
5
4
4
5
4
3
4
5
5
FTE-2030 -MULTIPLE PHASE SYSTEMS
4
5
5
3
4
5
4
3
5
5
FTE-2031 -MULTIPLE PHASE SYSTEMS I –PRACTICE
4
5
5
5
5
4
4
3
5
5
FTE-2040 -CONTROLLED RELEASE DRUG DELIVERY TECHNOLOGY I.
5
5
5
4
5
4
5
3
5
5
FTE-2041 -CONTROLLED RELEASE DRUG DELIVERY TECHNOLOGY -PRACTICE
5
5
5
4
5
5
5
3
5
5
FTE-2050 -TECHNOLOGY OF SEMI SOLID DOSAGE FORMS I
5
5
4
4
5
5
5
5
5
5
FTE-2051 -TECHNOLOGY OF SEMI SOLID DOSAGE FORMS I. -PRACTICE
5
5
5
5
5
5
5
5
5
5
FTE-2090 -CELL CULTURE IN DRUG DEVELOPMENT AND EVALUATION
3
5
3
4
4
3
5
4
5
5
FTE-2140-PHARMACEUTICAL BIOTECHNOLOGY II. MONOCLONAL DRUG MANUFACTURING TECHNOLOGY
3
4
2
4
4
3
5
5
4
4
FTE-2171 -DISSOLUTION RATE AND THE RELEASE KINETIC FROM DOSAGE FORMS-PRACTICE
5
5
3
4
4
5
3
1
5
5
FTE-2180 -THE EXCIPIENTS USED IN PHARMACEUTICAL TECHNOLOGY
5
5
5
4
5
4
5
4
5
5
FTE-2190-GOOD MANUFACTURING PRACTICES AND VALIDATION
5
5
5
5
5
5
4
4
5
5
FTE-2200-DISSOLUTION RATE AND RELEASE KINETICS FROM DOSAGE FORMS
5
5
4
5
4
5
3
1
5
5
SBE-ERA-85-ERASMUS INTERNSHIP
5
5
5
5
5
5
5
5
5
5
Course number related with program competency / 34
34
34
34
34
34
34
33
32
34
34
Program competency weight
154
160
133
143
146
141
125
107
161
153
* Relationship level 0 (none) and 5 (highest) are expressed in.